invasion phenotype
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (11)
Papers in which this entity is mentioned.
- Chromosomal instability as a driver of cancer progression. (2025)
- Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach. (2024)
- Towards understandings of serine/arginine-rich splicing factors. (2023)
- RNA splicing dysregulation and the hallmarks of cancer. (2023)
- Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. (2022)
- Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
- Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. (2020)
- RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. (2019)
- The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer. (2018)
- Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
- Mitogen-activated protein kinase modulates ethanol inhibition of cell adhesion mediated by the L1 neural cell adhesion molecule. (2013)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| invasion | phenotype | 14 | 23 |
| cell invasion | phenotype | 6 | 9 |